| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 08/16/2007 | US20070191341 N-Substituted Benzene Sulfonamides |
| 08/16/2007 | US20070191333 Antibacterial agents |
| 08/16/2007 | US20070191332 Compounds for the treatment of inflammatory disorders |
| 08/16/2007 | US20070191260 Novel indole derivative for alkylating specific base sequence of dna and alkylating agent and drug containing the derivative |
| 08/16/2007 | US20070190523 Method and compositions for identifying anti-hiv therapeutic compounds |
| 08/16/2007 | US20070190355 Material for organic electroluminescence device and organic electroluminescence device utilizing the same |
| 08/16/2007 | US20070189987 Composition comprising a monomeric compound with an optical effect, process using said composition, monomeric compound, polymer comprising the same and use thereof |
| 08/16/2007 | DE102006006588A1 Schnell freisetzende Irbesartan-haltige pharmazeutische Zusammensetzung Quick-release irbesartan-containing pharmaceutical composition |
| 08/16/2007 | CA2641579A1 N-hydroxyacrylamide compounds |
| 08/16/2007 | CA2640665A1 Pyridinone pyrazole urea and pyrimidinone pyrazole urea derivatives |
| 08/16/2007 | CA2640229A1 Sulfonamide derivatives to treat infection with hepatitis c virus |
| 08/16/2007 | CA2637771A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives |
| 08/15/2007 | EP1818333A1 Vanilloid receptor ligands and their use in treatments |
| 08/15/2007 | EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds |
| 08/15/2007 | EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/15/2007 | EP1817306A1 Triazoles and their use as bradykinin b1 receptor antagonists |
| 08/15/2007 | EP1817305A2 Compounds for the treatment of cns and amyloid associated diseases |
| 08/15/2007 | EP1817295A1 Triazole compounds that modulate hsp90 activity |
| 08/15/2007 | EP1817294A1 1,2,3,4-tetrahydropyrazin-2-yl acetamides and their use as bradykinin antagonists for the treatment of inflammation related disorders |
| 08/15/2007 | EP1817037A1 Triazole compounds suitable for treating disorders that respond to modulaiont of the dopamine d3 receptor |
| 08/15/2007 | EP1817030A2 Inducible nitric oxide synthase dimerization inhibitors |
| 08/15/2007 | EP1646620B1 Substituted piperidines as histamine h3 receptor ligands |
| 08/15/2007 | EP1597235B1 Non-nucleoside reverse transcriptase inhibitors |
| 08/15/2007 | EP1480640B1 Peroxisome proliferator activated receptor modulators |
| 08/15/2007 | EP1467974B1 Benzimidazole derivatives and their use as gnrh antagonists |
| 08/15/2007 | EP1440069B1 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors |
| 08/15/2007 | EP1435947B1 2-phenyl benzimidazoles and imidazo-¬4,5|-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| 08/15/2007 | EP1368028B1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation |
| 08/15/2007 | CN1331863C Imide analog compounds and its preparation method |
| 08/15/2007 | CN1331862C Di-aryl acid derivatives as PPAR receptor ligands |
| 08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
| 08/15/2007 | CN101018784A Bicyclic amides as kinase inhibitors |
| 08/15/2007 | CN101018783A Quinoxaline inhibitors of the HEDGEHOG signalling pathway |
| 08/15/2007 | CN101018782A Hydantoin compound for the treatment of inflammatory disorders |
| 08/15/2007 | CN101018781A Bicyclic N-anilide spirolactam CGRP receptor antagonists |
| 08/15/2007 | CN101018773A Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes. |
| 08/14/2007 | US7257287 Optical interleaver |
| 08/14/2007 | US7256207 Inhibitors of cathepsin S |
| 08/14/2007 | US7256189 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitors |
| 08/14/2007 | US7256188 3-aminoalkyl-2-aryl-indole derivatives and their use as GnRH antagonists |
| 08/09/2007 | WO2007089768A2 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them |
| 08/09/2007 | WO2007089149A2 Water-soluble cc-1065 analogs and their conjugates |
| 08/09/2007 | WO2007089018A1 Triazole derivative |
| 08/09/2007 | WO2007088996A1 Trisubstituted amine compounds as inhibitors of -cholesteryl ester transfer protein cetp |
| 08/09/2007 | WO2007088401A1 Indazole derivatives for treatment of alzheimer's disease |
| 08/09/2007 | WO2007071963A3 Quinazoline derivatives, process for their preparation and their use as anti-cancer agents |
| 08/09/2007 | WO2007071840A3 Compounds based on four aromatic rings, preparation and uses thereof |
| 08/09/2007 | WO2007059952A3 1-benzazepine-3-sulfonylamino-2-pyrrloridones as factor xa inhibitors |
| 08/09/2007 | WO2007059202A3 Pyrazolyl urea derivatives useful in the treatment of cancer |
| 08/09/2007 | WO2007044729A3 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
| 08/09/2007 | WO2007024843A3 Pyrimidinyl-pyrazole inhibitors of aurora kinases |
| 08/09/2007 | WO2007014290B1 Fungicidal carboxamides |
| 08/09/2007 | WO2006119400A3 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-trianzin-6-ones, and their use as fungicides |
| 08/09/2007 | WO2006087476A3 1,5-diarylpyrrole derivatives, preparation method thereof and application of same in therapeutics |
| 08/09/2007 | WO2006065601A3 Inhibitors of akt activity |
| 08/09/2007 | US20070185326 Heterocyclic compound |
| 08/09/2007 | US20070185324 Nitrogen-containing bicyclic heteroaryl compounds and methods of use |
| 08/09/2007 | US20070185169 2-Mercapto-4,5-Diarylimidazole Derivatives and the use thereof as Cyclooxygenase Inhibitors |
| 08/09/2007 | US20070185167 Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 08/09/2007 | US20070185166 1-( beta -D-glucopyranuronosyl)-3-[({4-chloro-3-[5-chloro-1-(2, 4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]benzoyl}(ethyl)amino)methyl]pyridinium chloride; ligands of oxytocin receptors; cream for topical use; control lypolysis, the storage of fat and cellulitus |
| 08/09/2007 | US20070185162 Substituted diketopiperazines as oxytocin receptor antagonists |
| 08/09/2007 | US20070185161 N-[3-(1-Ethyl-5-fluoro-indan-1-yl)-1H-indol-7-yl]-methanesulfonamide; for treating congestive heart disease, hypertension, and atherosclerosis |
| 08/09/2007 | US20070185159 Novel Nitrogen-Containing Heteroaryl Compounds And Methods of Use Thereof |
| 08/09/2007 | US20070185158 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 08/09/2007 | US20070185134 Inhibitors of cyclin dependent kinases as anti-cancer agent |
| 08/09/2007 | US20070185128 Compounds and compositions for treating obesity |
| 08/09/2007 | US20070185125 Pyridones useful as inhibitors of kinases |
| 08/09/2007 | US20070185121 Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents |
| 08/09/2007 | US20070185119 Therapeutic agents II |
| 08/09/2007 | US20070185115 Novel ureido-and amido-pyrazolone derivatives |
| 08/09/2007 | US20070185112 Piperidine/piperazine-type inhibitors of p38 kinase |
| 08/09/2007 | US20070185111 N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(3 -methyl-5-isothiazolyl)-1-phthalazinamine; anticarinogenic agents; antiproliferative agents; antiinflammatory agents; antitumor agents |
| 08/09/2007 | US20070185106 Pyrrole derivatives as gonadotropin releasing hormone (gnrh) antagonists |
| 08/09/2007 | US20070185094 Novel 3-substitued-1,4-benzodiazepines |
| 08/09/2007 | US20070185093 Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands |
| 08/09/2007 | US20070185091 Bicyclic Heterocycles, Pharmaceutical Compositions Containing These Compounds, Their Use and Processes for Preparing Them |
| 08/09/2007 | US20070185089 Benzazepine derivatives for the treatment of neurological and psychiatric disorders |
| 08/09/2007 | US20070185088 M3 muscarinic acetylchoine receptor antagonists |
| 08/09/2007 | US20070185075 Pyrimidine derivatives |
| 08/09/2007 | US20070184979 Novel sulfonylpyrroles |
| 08/09/2007 | US20070184061 Indolylmaleimide derivatives |
| 08/09/2007 | CA2641899A1 Water-soluble cc-1065 analogs and their conjugates |
| 08/09/2007 | CA2641345A1 Indazole derivatives for treatment of alzheimer's disease |
| 08/09/2007 | CA2640398A1 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them |
| 08/08/2007 | EP1816127A1 Triazine derivatives for use as selective npy (y5) antagonists |
| 08/08/2007 | EP1815859A2 Halimide, a cytotoxic marine natural product, and derivatives thereof |
| 08/08/2007 | EP1814874A1 N-heterocyclyl phthalic acid diamides as insecticides |
| 08/08/2007 | EP1814866A2 Gonadotropin releasing hormone receptor antagonists |
| 08/08/2007 | EP1814863A1 Indazole sulphonamide derivatives |
| 08/08/2007 | EP1814861A1 Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents |
| 08/08/2007 | EP1814849A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 08/08/2007 | EP1814552A2 Compounds for treating protein-kinase mediated disorders |
| 08/08/2007 | EP1814545A2 Compounds and compositions as protein kinase inhibitors |
| 08/08/2007 | EP1611121B1 Pyridazinone derivatives as cdk2-inhibitors |
| 08/08/2007 | EP1471908B1 Process for preparing losartan potassium with improved flowability |
| 08/08/2007 | EP1351950B1 Isoquinolinyl aroyl pyrrole compounds for the treatment of central nervous system disorders |
| 08/08/2007 | EP1343530B1 Oral pharmaceutical composition containing a block copolymer |
| 08/08/2007 | EP1255752B1 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/08/2007 | CN1330657C Novel piperidine and piperazine derivatives |
| 08/08/2007 | CN1330644C Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide |